Wednesday, August 12, 2026
News

Govt raises TB patient aid to Rs 1,000 per month, reduces drug-resistant TB treatment duration: Nadda

SocialTwist Tell-a-Friend    Print this Page   COMMENT

New Delhi | August 11, 2026 11:27:47 PM IST
Union Health Minister J P Nadda on Tuesday said the government has doubled the financial support provided to tuberculosis (TB) patients from Rs 500 to Rs 1,000 per month to help them maintain a nutritious diet.

He also emphasised the need to sensitise Members of Parliament, Members of Legislative Assemblies and other public representatives to strengthen the campaign against TB.

Nadda made the remarks while interacting with parliamentarians from Keralam and Karnataka on the 'TB Mukt Bharat Abhiyaan', highlighting the measures being taken by the government to eliminate tuberculosis and reduce its prevalence in the country.

Nadda said TB patients are provided medicines free of cost, including those undergoing treatment through private doctors.

"It is not only the medicine, but we also give free medicine. Even if it's a private doctor who is treating, the medicines are given free. So the medicine part is not only there, but we also give them Rs 1,000 per month to see to it that they take a good diet," Nadda said.

He stated that the enhanced financial assistance is aimed at ensuring that patients are able to maintain a proper diet during their treatment.

The Health Minister said the government, under the leadership of Prime Minister Narendra Modi, has undertaken several measures under the TB Mukt Bharat Abhiyaan to eliminate tuberculosis and reduce its prevalence in India.

Stressing the government's efforts to make tuberculosis (TB) treatment shorter and more patient-friendly, Union Health Minister Nadda said the treatment duration for drug-resistant TB has been reduced from 12-24 months to six months under the BPaL regimen.

He stated that the treatment for drug-sensitive TB patients is also completed within six months through fixed-dose combinations of medicines.

"There are drug-resistant patients. So for them, the medicine is used to continue for 12 to 24 months. Now, it has been reduced to six months, which we call the BPaL regimen. So that regimen is what we are introducing. So the burden is becoming less, and it is also patient-friendly," Nadda added. (ANI)

 
  LATEST COMMENTS ()
POST YOUR COMMENT
Comments Not Available
 
POST YOUR COMMENT
 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
INDIA WORLD ASIA
Government pushes its legislative agenda...
Inquiry report on Justice Yashwant Varma...
Grand finale of Gautam Adani's 'Vande Bh...
Rajya Sabha passes Tribunals Reforms Bil...
Centre has constituted multi-sectoral te...
Al Falah Trust PMLA case: Property deriv...
More...    
 
 Top Stories
Himachal: 50 Tibetans in Shimla hol... 
Pakistan: Karachi Court orders Civi... 
Nepal: Bodies of three elite Nepali... 
Inquiry report on Justice Yashwant ... 
Government pushes its legislative a... 
Himira Rakhi gift pack launched; Se... 
MoHUA holds national conference on ... 
Very significant for him, says US l...